News

Teewinot Life Sciences' Irish Subsidiary, Full Spectrum Laboratories, Ltd. Secures a U.S. patent for the biosynthesis of cannabinoids.

Houston Methodist Hospital researchers have advanced a potential treatment for metaplastic breast cancer—the most aggressive subtype of triple negative breast cancer, into patients in just under four years.

GRAIL will use the proceeds to continue the development and validation of its cancer test which is designed to measure circulating tumor DNA in the blood by applying Illumina sequencing technology.

New research has revealed the function of a widely shared enzyme component, the Zf-GRF domain, as a critical molecular tool necessary for manipulating DNA during repair processes.

Study reveals how cancer can become resistance to checkpoint inhibitor treatments.

Scientists at the University of North Carolina at Chapel Hill have developed a method to control proteins inside live cells with the flick of a switch, giving researchers a tool for pinpointing the causes of disease using light.

A family of enzymes known as KDM5 are the subject of a recent Yale study, they have previously been shown to be involved in cancer cell growth.

Developed at the University of Massachusetts Medical School the new RNAi-based treatment has shown promise in a Phase I clinical trial.

Anyone who has allowed a child to "help" with a project quickly learns that kids, no matter how intelligent or eager, are less competent than adults. Teenagers are more capable—but, as every parent knows, teens can be erratic and unreliable.

What you see is not always what you get. And that, researchers at The Rockefeller University have discovered, is a good thing.